Онлайн КрасотаКаталог

Брошюра «Клинические исследования пептидных биорегуляторов» Электронная версия на английском языке — страница 60

Книги и пособия · 125 страниц · 0.7 МБ · Полное издание

Читать текстСкачать PDF
Suprefort® Biologically active food supplement SUPREFORT® is a complex of low molecular weight peptides with a molecular weight of up to 5000 Da, obtained from the pancreas of young animals - calves not older than 12 months of age or pigs. The isolated peptides have a tissue-specific effect on the pancreas cells, restoring metabolism and normalizing their functional activity. SUPREFORT® is available in tablets or capsules containing 10 mg of active peptides. SUPREFORT® was administered to patients orally 10-15 minutes before meals, 1-2 capsules 2 times a day for 10-20 days, depending on the severity of the pathological process. Clinical trials of SUPREFORT® were carried out at the Medical Center of the St. Petersburg Institute of Bioregulation and Gerontology, SZO RAMS in patients with chronic pancreatitis in remission and pa- tients with type II diabetes mellitus in the period from November 2005 to January 2006. Dysregulation of physiological functions and pathological changes in the pancreas causes diseases with digestive and metabolic disorders manifestations. The consequence of a progressive inflammatory process in the pancreas is, as a rule, dystrophic pro- cesses, accompanied by a violation of the formation and secretion of pancreatic digestive enzymes, characteristic of chronic pancreatitis. In the presence of disorders of insulin secretion, the symptoms of «secondary» diabetes develop. Diabetes is one of the most common endocrine diseases: it affects about 1-2% of the world’s popula- tion. In addition, there is almost the same number of patients with latent diabetes and genetically pre- disposed to this disease. The manifestations of diabetes in each case represent an integrated reaction to the combined action of numerous factors in different combinations (genetic predisposition, chemical and infectious agents of the external environment, autoimmune processes, nutrition, physical activity, psychological stress, etc.). The discovery of new syndromes (diabetes caused by the formation of an- tibodies to insulin receptors; diabetes caused by a genetic defect in the structure of insulin, etc.) justi- fies the constant need to supplement the existing classifications of the disease. The disease’s potential latent and asymptomatic forms, occurring without clinical manifestations, draw particular attention to prognosis, prevention, and treatment (1, 3, 6, 7, 8). For the treatment of chronic pancreatitis, diet therapy and enzyme preparations (pancreatin, panzinorm), and others are mainly used (5) Treatment of diabetes without clinical manifestations includes diet therapy and herbal medicine (2, 4). CLINICAL CHARACTERISTICS OF PATIENTS The distribution of patients who took part in the study by sex and age is presented in Table 1. Treatment with SUPREFORT® was carried out in 34 patients (18 men and 16 women) with diagnoses of «Chronic pancreatitis,» latent form (12 people), and «Diabetes mellitus type II, latent form» (22 people). Patients with chronic pancreatitis complained of loss of appetite, belching, flatulence, rumbling in the abdomen, and stool disorders. By random distribution, two groups of patients were formed, equal in sex, age, di- agnosis: the primary group included 12 patients (8 men, 4 women), the control group - 8 patients (4 men, 4 women). Distribution of patients by diagnosis, sex and age. Table 1 Diagnosis Age Male Female Total Control Primary Control Primary Control Primary Group Group Group Group Group Group Chronic pancreatitis 39-68 4 8 4 4 8 12 Type II diabetes mellitus 42-64 6 10 11 12 17 22 Total: 10 18 15 16 25 34 Patients in the control group received conventional treatment. In addition to conventional drugs, patients of the primary group were prescribed SUPREFORT® 1-2 capsules 2 times a day before meals for 15 days.

Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.

Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.